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Abstract. Colchicine-tubulin dimer complex, a potent inhibitor of normal microtubule 
assembly undergoes extensive self-assembly in the presence of 1 × 10–4 Μ zinc sulphate. 
Polymers assembled from colchicine-tubulin dimer complexes are sensitive to cold. 
Although colchicine can be accomodated within the polymeric structure, the drug cannot 
bind to tubulin subunits in the intact polymers. This is evidenced by the fact that (a) the 
colchicine binding activity of tubulin is lost when allowed to polymerize with zinc sulphate, 
(b) the loss in colchicine binding could be prevented by preincubation of tubulin with 
1 × 10–3 Μ CaCl2 or 1 × 10–5 Μ vinblastine sulphate and finally (c) no loss in colchicine 
binding activity is found when tubulin is kept at a concentration far below the critical 
concentration for polymerization. Unlike colchicine, its B-ring analogues desacetamido 
colchicine (devoid of the B-ring subtituent) and 2-methoxy-5- (2’,3’,4’-trimethoxyphenyl) 
tropone (devoid of the B-ring) can bind to tubulin subunits in the intact polymers. 
Thus we conclude that the colchicine binding domain on the tubulin molecule is mostly (if 
not completely) exposed in the Zn(II)-induced polymers and the B-ring substituent plays a 
major role in determining the binding ability of a colchicine analogue to tubulin in the 
intact Zn(II)-induced sheets. 
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Introduction 
 
The alkaloid colchicine was known as an inhibitor of mitosis long before the 
discovery of microtubules (Dustin, 1978). Extensive studies on the mechanism of 
action of colchicine have established that it exerts its antimitotic action through 
binding to tubulin. Although tubulin can bind colchicine, however, tubulin within 
the assembled microtubule cannot bind colchicine (Wilson and Meza, 1973). In vitro 
microtubule assembly is inhibited by substoichiometric concentrations of colchicine; 
half maximal inhibition occurs when only 2% of the unpolymerized tubulin is 
complexed with drug (Olmsted and Borisy, 1973; Wilson and Bryan, 1974; Margolis 
and Wilson, 1977). A similar mechanism also appears to be applicable to in vivo 
poisoning; in the case of mitosis, colchicine exerts its influence when only a small 
fraction of the cellular pool of tubulin is complexed with drug. 
This substoichiometric poisoning of microtubule assembly has been explained by 
the Capping of the growing end of microtubules by the drug-tubulin complex 
(Margolis and Wilson, 1977). Sternlicht and Ringel (1979) explained the above 
phenomena on the basis of a copolymerization model in which both tubulin and 
colchicine-tubulin dimer (CD) complex are incorporated into microtubules. 
 
 
*To whom all correspondence should be addressed. 
Abbreviations used: CD, Colchicine-tubulin dimer; GTP, Guanosine-5’–triphosphate; SDS, sodium 
dodecyl sulphate; pp (CH2) pG, guanylyl-5’–methylene diphosphonate. 
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According to their model, incorporated CD complexes decrease the affinity of the 
microtubule end for further addition of tubulin dimer. It has been reported from this 
laboratory (Banerjee et al., 1982) that even only CD complexes could be polymerized 
in the presence of zinc sulphate. Analysis of the polymerized products harvested in 
the presence of [3H]-colchicine indicates the incorporation of 0·5 mol of colchicine per 
mol of tubulin. From this observation, it is apparent that the colchicine binding site 
on tubulin might be different from the tubulin-tubulin interaction sites involved in 
the process of Zn(II)-induced assembly. Thus, the question may arise as to whether 
the colchicine binding site in the Zn(II)-induced polymer is buried, if not, whether 
colchicine could bind to intact Zn(II)-induced polymer. Our studies on this aspect 
revealed that the preformed sheets cannot bind colchicine. However, colchicine 
analogues with no substituents in the B-ring (of colchicine) (figure 7) such as 
desacetamido colchicine and 2-methoxy-5-(2’,3’,4’–trimethoxyphenyl) tropone 
(devoid of B-ring) could bind to intact Zn(II)-induced sheets suggesting that the size 
of the B-ring of colchicine plays an important role in determining the binding 
properties of colchicine to Zn(II)-induced sheets. 
 
Materials and methods 
 
Materials 
 
Colchicine, Guanosine-5’-triphosphate (GTP) (Grade IIS), 2-(N-morpholino)ethane-
sulphonic acid (MES) and sodium dodecyl sulphate (SDS) were products of Sigma 
Chemical Company, St. Louis, Missouri, USA. Colcemid was obtained from Κ and K. 
B-ring modified analogues of colchicine were the kind gifts of Dr. Thomas J. Fitzgerald 
of School of Pharmacy, Florida A and Μ University, Tallahasee, Florida, USA. 
DEAE-cellulose (DE 52) and DEAE-cellulose paper (DE 81) were obtained from 
Whatman Ltd., England. [3H]-Colchicine (ring C, methoxy 3H) was a product of 
New England Nuclear Corporation, USA. Fresh goat brains were obtained from a 
local slaughter house. 
 
Purification of tubulin 
 
Tubulin was purified from goat brain in PMG buffer (10 mM potassium phosphate, 
pH 7·0; 10 mM MgCl2; 0·1 mM GTP) according to Weisenberg et al. (1968), except 
that DEAE-cellulose was used instead of DEAE-sephadex. The active fractions as 
judged from a colchicine-binding assay (Williams and Wolf, 1972) were pooled, 
concentrated by overnight dialysis at 0°C against 100 volumes of 8 Μ glycerol in 
buffer A (100 mM MES, pH 6·4; 0·5 mM MgCl2; 1·0 mM GTP) and stored at 
– 70°C. The purity of tubulin was checked by SDS-polyacrylamide gel electropho- 
resis according to Laemmli (1970). Protein concentrations were determined as 
described by Lowry et al. (1951) using bovine serum albumin as standard. 
 
Spectrophotometric assay of tubulin assembly 
 
Assembly reactions were performed at 37°C in buffer A and monitored spectrophoto-
metrically in a Cary 17D spectrophotometer recording at 400 nm. A wavelength of 
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400 nm was selected so as to minimize the absorption of colchicine. Temperature of 
the cuvettee chamber was maintained at 37°C using an LKB model 2209 circulator. 
 
[3Η]-Colchicine-binding assay 
 
[3H] -Colchicine binding assay was performed according to the DEAE-cellulose filter 
disc method of Weisenberg et al. (1968) as modified by Williams and Wolf (1972). 
 
Fluorometric assay for drug binding 
 
The binding of unlabelled drug (colchicine, desacetamido colchicine and 2-methoxy- 
5-(2’,3’,4’-trimethoxyphenyl) tropone to tubulin was assayed by the fluorometric
method according to Bhattacharyya and Wolff (1974). Fluorescence was measured at 
37°C in a Perkin Elmer model MPF 44B Spectrofluorometer. Samples were excited 
at a wavelength of 380 nm, emission was scanned from 390–550 nm. 
 
Electron microscopy 
 
Electron microscopy was done according to Johnson and Borisy (1979) using 1% 
uranyl acetate. 
 
Results 
 
Colchicine binding activity of tubulin upon assembly in the presence of Zn(II) 
 
It has been demonstrated from this laboratory that suprastoichiometric con- 
centrations of colchicine do not inhibit the assembly of tubulin in the presence of 
zinc sulphate (Banerjee et al., 1982). We also demonstrated that even CD complexes 
are capable of assembly in the presence of 1 × 10–4 Μ zinc sulphate. Electron 
microscopic examination of the assembly products obtained from pure tubulins by 
Zn(II) are shown in figure 1. Negatively stained samples showed that at the highest 
Zn(II) concentration (1 ×10–4M) the polymers are sheets in nature. This is in 
agreement with the results of others (Larsson et al., 1976; Wallin et al., 1977; Gaskin 
and Kress, 1977; Haskins et al., 1980). The colchicine content of the Zn(II)-induced 
polymers harvested from the [3H]-labelled CD complexes have been determined and 
found to be 0·4–0·5 mol of colchicine per mol of tubulin dimer. It appears from this 
that the colchicine-binding site and the tubulin-tubulin interaction sites are different 
in the case of Zn(II)-induced assembly. The incorporation of the colchicine molecule 
into the Zn(II)-induced polymer further indicates that the polymer could accommodate 
the drug molecule within its lattice. Thus, the question may arise as to whether the 
preformed polymers bind colchicine. Therefore, experiments were designed to study 
the colchicine-binding property of 6S tubulin after assembly in the presence of zinc 
sulphate. 
For this purpose, aliquots of tubulin were incubated with various concentrations 
of zinc sulphate at 37°C for 30 min; samples were subsequently incubated further 
with [3H]-colchicine (1 × 10–6 M) at 37°C for 30 min and the bound colchicine was 
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Figure 1. Electron micrographs of Zn(II)-tubulin polymer. DEAE-tubulin (0·7 mg/ml) in 
buffer A was polymerized at 37°C for 30 min in the presence of 1 × 10–4 Μ ZnSO4. A 5 μl 
aliquot of the polymerized sample was loaded onto a 400 mesh copper grid and negatively 
stained with 1% uranyl acetate as described in the ‘materials and methods’. Grids were 
examined in a Phillips Model EM301 electron microscope under an accelerating voltage of 
60 KV ( × 19,000). 
 
 
assayed (figure 2). As shown in figure 2 preincubation of tubulin with ZnSO4 at 
concentrations upto 1 × 10–5 Μ had no effect on the colchicine-binding activity 
while at concentrations above 2 × 10–5 Μ it caused a gradual inhibition of colchicine 
binding activity. The maximum inhibition occurred in the range of 5 × 10–5–l × 
10–4 Μ ZnSO4 and further increase in the zinc sulphate concentration did not result 
in any further increase in the extent of inhibition. Infact, Zn(II) at 1 × 10–5 Μ does 
not induce assembly but the induction of assembly occurs at a Zn(II) concentration 
above 2 × 10–5 Μ (figure 3). It is, therefore, conceivable that the inhibition of colchi- 
cine binding activity of tubulin upon incubation with ZnSO4 is a consequence of 
polymerization of tubulin. That this inhibition in colchicine binding is not due to the 
blocking of sulphydryl groups is evidenced by the fact that the inclusion of mercapto-
ethanol into the reaction mixture could not overcome the inhibition. That the 
inhibition is not due to the inactivation (or denaturation) of tubulin is shown by the 
total recovery of the colchicine-binding activity on treatment with Zn(II)-chelators 
like ethylenediamine tetraacetic acid or o-phenanthroline (data not shown). 
Moreover, this inhibition in colchicine binding could be prevented by incubation of 
tubulin with its assembly inhibitor such as 1 × 10–3 Μ calcium chloride or 
1 × 10–5 Μ vinblastine sulphate (prior to the addition of zinc sulphate). The above 
results indicate that the loss of colchicine-binding could be either due to the 
polymerization of tubulin or due to an alteration in the colchicine-binding site by the 
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Figure 2. Colchicine binding activity of tubulin upon assembly in the presence of ZnSO4. 
Aliquots of DEAE-purified tubulin (0·75 mg/ml) in buffer A were incubated with different 
concentrations of ZnSO4 at 37°C for 30 min. Colchicine binding activity of the samples 
were subsequently determined by incubating the samples with [3H]-colchicine (1 × 10–6M) 
at 37°C for 30 min. Colchicine binding assays were carried out with DE-81 filter paper as 
described under ‘materials and methods’. Binding activity of each sample was expressed as a 
per cent activity remaining compared to a sample containing no ZnSO4 (Ο). A second set of 
samples was preincubated with either 1 × 10–3 Μ CaCl2 (?) or 1 × 10–5 Μ vinblastine 
sulphate (?) prior to the incubation with ZnSO4. For non polymerizing condition; aliquots 
of DEAE-tubulin (0·05 mg/ml) in buffer A were incubated with different concentration of 
ZnSO4 at 37°C for 30 min and the colchicine binding activity of the samples were 
determined (?) (taken from Banerjee, 1981). 
 
binding of Zn(II) to tubulin. However, the latter possibility seems to be unlikely since 
Zn(II) exhibits no inhibitory effect when tubulin concentration was kept far below 
the critical concentration* for polymerization (figure 2). Moreover, the loss in 
colchicine-binding activity has been found to correlate with the loss of tubulin from 
the supernatant (table 1). A slight variation in the results obtained by two different 
methods might result due to the binding of colchicine to ends of tubulin sheets. All 
these data clearly indicate that the intact Zn(II)-induced polymer binds colchicine 
very poorly. 
 
Studies with colchicine analogue 
 
From the previous results, it is clear that although the colchicine molecule could be
accomodated with the Zn(II)-indueed polymers, the drug binds to intact sheets very
 
*Critical concentrations for polymerization of DEAE-purified tubulin in the presence and absence of 
1 × 10–4 Μ ZnSO4 are 0·12 mg/ml and 1·4 mg/ml respectively (Banerjee et al., 1982). 
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Figure 3. Assembly of DEAE-tubulin at different Zn (II) concentrations. 
DEAE-tubulin (0·7 mg/ml) in buffer A was incubated at 37°C in the presence of different 
concentrations of ZnSO4 and the polymerization was monitored turbidimetrically at 
400 nm. ZnSO4 concentrations were as follows: None or 1 × 10–5 M (O), 2 × 10–5 M (●), 
5 × 10–5 M (▲) and 1 × 10–4 M (■). Arrow indicates the time when cuvette was placed at 
0°C. 
 
Table 1. Correlation of the colchicine binding inhibition with the amount of protein pelleted by 
centrifugation. 
aCounts/min/0·l ml reaction mixture. bSupernatants were examined for protein. 
Aliquots of DEAE-purified brain tubulin were incubated at different protein concentrations in bluffer A 
with or without 1 × 10–4 M ZnSO4 at 37°C for 30 min. In one set of experiments, colchicine binding of 
samples were determined by further incubating the samples with [3H]-colchicine (1 × 10–6 M) at 37°C for 
30 min. In the other set of experiments, samples polymerized in the presence of ZnSO4 were centrifuged at 
120,000 g for 30 min at 25°C to pellet down the polymer. 
 
poorly. Possible explanation for the burial of the colchicine-binding site in the Zn(II)- 
induced polymer might be that although the tubulin-tubulin interaction sites and the 
colchicine-binding sites in native tubulin are different, it is possible that the 
colchicine-binding site and the tubulin-tubulin interaction sites involved in sheet 
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formation may overlap spatially. An alternate mechanism might be that colchicine 
binding to tubulin which requires a change in conformation of the tubulin molecule 
(Ventilla et al., 1972; Garland, 1978; Lambeir and Engelborghs, 1981; Detrich et al., 
1982; Andreu and Timasheff, 1982a) is hindered due to a restricted movement of 
tubulin in the assembled state compared to the free state. 
To test these possibilities, we chose certain colchicine analogues viz., desacetamido 
colchicine and 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone which are known to 
bind tubulin at the same site where colchicine binds (Ray et al., 1981). Further, they 
are structurally related to, yet less bulky than colchicine (figure 7). 
 
Effect of colchicine analogues on the Zn(II) tubulin sheet formation: We have 
demonstrated that colchicine is ineffective at inhibiting the Zn(II)-tubulin sheet 
formation (Banerjee et al., 1982). To test the effect of colchicine analogues on Zn(II)-
tubulin sheet formation, we preincubated brain tubulin with 1 × 10–5 Μ of either 
analogue at 37°C for 30 min. Assembly was subsequently initiated by the addition of 
1 × 10–4 Μ ZnSO4 (figure 4). As shown in the figure, tubulin complexed with desa-
cetamido colchicine and 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone could 
polymerize well in the presence of ZnSO4. In the case of the drug-treated samples the 
rate of assembly was less although the steady state turbidities were almost the same 
as that of the control sample. In this context it should be mentioned that similar 
behaviours of colchicine and podophyllotoxin in the assembly of microtubule protein 
in the presence of a GTP analogue,  guanylyl-5’-methylene diphosphonate (pp (CH2) 
 
 
Figure 4. Effect of colchicine analogues on the Zn (II)-tubulin assembly. 
Aliquots of DEAE-purified brain tubulin (0·7 mg/ml) in buffer A were incubated at 37°C 
for 30 min either alone (Ο) or in the presence of 1 × 10–4 Μ desacetamido colchicine (Δ) or 
1×10–4 Μ 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone (●). Samples were subse-
quently polymerized at 37°C in the presence of 1 × 10–4 Μ ZnSO4. 
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pG) were first reported by Sandoval and Weber (1979). Recently it has been reported 
that the tubulin-colchicine complex undergoes polymerization under the same in 
vitro conditions which promote microtubule assembly, however, the resulting 
polymers showed amorphous structure as well as large aggregates which appear to 
be fibrous and did not reveal any organized structure (Saltarelli and Pantaloni, 1982; 
Andreu and Timasheff, 1982a,b). 
 
 
Effect of colchicine analogues on the preformed Zn(II)-tubulin sheets: In order to 
study the effect of colchicine analogues on the preformed Zn(II)-tubulin sheets, 
tubulin was assembled in the presence of 1 × 10–4 M ZnSO4 at 37°C for 30 min. 
Steady state polymers were further incubated with 1 × 10–4 Μ drug at 37°C and the 
turbidity was monitored. It has been observed that the turbidity remained almost 
unchanged for about an hour in the case of desacetamido colchicine and 2-methoxy- 
5-(2’,3’,4’–trimethoxyphenyl) tropone treated samples whereas there are about 
15–20% decrease in the optical density in the case of colchicine treated one. These 
results indicate that Zn(II)-tubulin sheets are stable to treatment with desacetamido 
colchicine and 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone whereas they are 
partially susceptible toward colchicine (data not shown). 
 
 
Binding of colchicine analogues to Zn(II)-tubulin sheets: Unlike colchicine, its two 
B-ring analogues, desacetamido colchicine and 2-methoxy-5-(2’,3’,4’-trimethoxy- 
phenyl) tropone bind to tubulin at a faster rate (Ray et al., 1981). Like colchicine, the 
analogues upon binding to tubulin exhibit fluorescence emission maxima at 430 nm. 
To study the binding of these analogues to intact Zn(II)-induced polymers tubulin 
was assembled to steady state in the presence of zinc sulphate (1 × 10–4 M) and 
subsequently incubated further with 1 × 10–4 M drug at 37°C for 15 min. The 
fluorescence spectra of the drug treated polymerized samples were scanned and 
compared with an identically treated sample of unpolymerized tubulin. The results of 
such a study employing colchicine, desacetamido colchicine and 2-methoxy-5-(2’,3’,4’-
trimethoxyphenyl) tropone have been depicted in figure 5. As evident from the figure, 
there is a marked difference between the colchicine fluorescence of a sample of 
unpolymerized tubulin and that of an identical sample polymerized to steady state in 
the presence of zinc sulphate. The fluorescence of the polymerized sample is about 
30–35% of that of the unpolymerized one (figure 5A). In fact, this 30–35% of 
fluorescence is due to the free tubulin after the colchicine-treatment of polymers. The 
total free tubulin is the sum of the tubulin present in equilibrium with the polymers 
at steady state (critical protein concentration for polymerization) plus the amount 
derived from the depolymerization of polymers by colchicine treatment (1 × 10–4 M). 
This result is consistent with the conclusion obtained from figure 2 that the Zn(II)- 
induced polymers cannot bind colchicine. In contrast, the fluorescence emission 
spectra of both desacetamido colchicine (figure 5B) and 2-methoxy-5-(2’,3’,4’-
trimethoxyphenyl) tropone (figure 5C) were almost the same with either polymerized 
or unpolymerized sample of tubulin. These results clearly indicate that unlike 
colchicine, its two B-ring analogues could bind to intact Zn(II)-induced polymers of 
tubulin. In all cases, the fluorescence emission intensity was corrected for protein in 
the absence of drug.
The same conclusion is further confirmed by the [3H]-colchicine binding assay. It 
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Figure 5. Binding of colchicine and its analogues to tubulin before and after assembly in 
the presence of ZnSO4. Aliquots of DEAE-purified tubulin (0·98 mg/ml) in buffer A were 
polymerized in the presence of 1 × 10–4 M ZnSO4 at 37°C for 30 min. These polymerized 
samples together with polymerized tubulin samples were incubated with 1 × 10–4 M 
drug at 37°C for 15 min. Fluorescence emission spectra of the samples were recorded 
subsequently from 390–500 nm after exciting at 350 nm. Fluorescence of both polymerized (---) 
and unpolymerized (—) samples are presented (A), Colchicine; (B), desacetamido colchicine; 
(C), 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone. 
Appropriate corrections were made for scattering of assembled tubulin in the absence of 
drug (Banerjee, 1981). 
 
has been reported from this laboratory (Ray et al., 1981) that colcemid, desacetamido 
colchicine and 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone bind to tubulin at 
the same site at which colchicine binds. Thus it has been possible to study the 
binding of these B-ring analogues to the intact Zn(II)-induced polymers in an 
experiment in which [3H]-colchicine could be used as a probe to detect the presence 
of drug molecules bound at the colchicine binding site on tubulin. 
In this study, tubulin was polymerized in the presence of 1 × 10–4 M zinc sulphate 
to steady state and the polymers were subsequently incubated further with 1 × 10–4 M 
unlabelled drugs at 37°C for 30 min. The drug treated polymers were pelleted by 
warm (25°C) centrifugation at 120,000 g for 30 min. The pellets were resuspended in 
buffer A, depolymerized with EDTA and were incubated with [3H]-colchicine. The 
course of [3H]-colchicine binding was followed in each case and was compared to 
that of a control pellet obtained without treatment by any drug. The results of such 
an experiment employing colchicine, colcemid, desacetamido colchicine and 2- 
methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone have been summarized in figure 6. As 
shown in the figure, the uptake of [3H]-colchicine for colchicine and colcemid- 
treated polymer pellets are almost identical to that of the untreated control pellet, 
which clearly indicates that those two drugs cannot bind to the intact polymers 
significantly. In contrast, the uptake of radioactivity for desacetamido colchicine 
and 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone-treated pellets were markedly 
inhibited as compared to that of the control pellet. A small increase in the uptake of 
radioactivity for the 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone-treated sample 
is probably due to the reversible binding property of this drug to tubulin (Ray et al. 
1981) so that some bound drug is released during the chasing period and [3H]- 
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Figure 6. Binding of colchicine and its analogues to intact Zn(II)-induced polymers of 
tubulin. Aliquots of DEAE-tubulin (1·2 mg/ml) in bluffer A were assembled at 37°C for 
30 min in the presence of l × 10–4 M ZnSO4. Assembled mixtures were subsequently 
incubated with 1 × 10–4 M unlabelled drugs at 37°C for 15 min. Polymers were pelleted by 
warm (25°C) centrifugation at 120,000 g for 30 min. Pellets were then resuspended, 
depolymerized with 1 × 10–3 M EDTA and subsequently incubated with [3H]-colchicine 
(1 × 10–6 M) at 37°C. The kinetics of uptake of [3H]-colchicine was followed in each case by 
withdrawing suitable aliquots from the reaction mixture at different intervals and measuring 
the bound [3H]-colchicine by DE-81 filter binding assay as described under ‘materials and 
methods’. 
(1), Control pellet obtained in the absence of any drug; (2), pellet obtained in the presence of 
colcemid; (3), pellet obtained in the presence of colchicine; (4), pellet obtained in the presence 
of 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone; (5), pellet obtained in the presence of 
desacetamido colchicine. 
 
 
Figure 7. Structure of colchicine and its analogues. 
 
colchicine gets bound to those vacant sites. These results clearly indicate that unlike 
colchicine and colcemid (both of which have a B-ring substituent), desacetamido 
colchicine (devoid of B-ring substituent), and 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) 
tropone (devoid of B-ring) can bind to tubulin subunits in the intact Zn(II)-induced 
polymers. 
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Discussion 
 
Although copolymerization of CD complex and tubulin dimer has been reported in 
normal microtubule assembly (Sternlicht and Ringel, 1979), the ratio of CD tubulin 
dimer in those microtubules is very low. It has been reported from our laboratory 
(Banerjee et al., 1982) that CD complexes could also be polymerized in the presence 
of ZnSO4. The incorporation of colchicine into the polymer structure has been 
confirmed using [3H]-colchicine. From this behaviour of colchicine, it is conceivable 
that the tubulin-tubulin interaction sites involved in the process of Zn(II)-induced 
assembly are different from the colchicine-binding site of tubulin. Thus, from the 
ability of colchicine-tubulin complex to form sheets in the presence of ZnSO4 one 
might expect that the drug binding sites on tubulin subunits are exposed on the wall 
of Zn(II)-tubulin sheets. In order to test this possibility, the colchicine binding 
properties of the preformed Zn(II)-tubulin sheets have been studied. The results 
shown in figure 2 clearly indicate that the colchicine binding activity of tubulin is lost 
upon assembly in the presence of Zn(II). That the loss in the drug binding activity is 
not due to the inactivation or poisoning of tubulin is confirmed by the fact that 
preincubation of tubulin with Ca(II) or vinblastine sulphate or treatment of sheets 
with Zn(II)-chelators (to depolymerize them) could restore the drug binding activity. 
Moreover, the inhibition of the drug binding activity was not observed when tubulin 
was incubated with Zn(II) at a protein concentration far below the critical 
concentration for assembly in the presence of Zn(II). The above results indicate that 
the Zn(II)-tubulin sheets bind colchicine very poorly. 
The assembly of tubulin at diferent Zn(II) concentrations was studied and it was 
found that inhibition of drug binding activity by Zn(II) was exhibited only when 
assembly was induced. Zn(II) at 1 × 10–5 neither induced assembly (figure 3) nor 
inhibited the colchicine binding activity of tubulin (figure 2). Moreover, the data 
obtained by the colchicine binding study correlated well with that obtained by the 
analysis of pellets after warm centrifugation (table 1). 
Although the Zn(II)-induced assembly and normal microtubule assembly differ 
strikingly with respect to their sensitivity to colchicine, both polymers resemble each 
other with respect to colchicine binding properties i.e., neither of them can bind 
colchicine. Thus, the assurance of accommodating a drug molecule into a polymer 
structure does not necessarily mean that the polymer will bind the drug. One 
possible explanation for the inability of Zn(II)-induced polymers to bind colchicine 
might be that the alteration in conformation of the tubulin molecule which is 
required for colchicine binding (Garland, 1978; Lambier and Engelborgh, 1981) is 
hindered in the assembled state as compared to the free state. Infact, this hindrance is 
not unlikely for tubulin in the assembled state where each tubulin is anchored by 
adjacent tubulin molecules. An alternative mechanism might be that although the 
tubulin-tubulin interaction site is different from the colchicine binding site (at least in 
the case of Zn(II)-induced polymers), however, it is possible that in the assembled 
state, the colchicine binding site is partially covered (sterically crowded) by the 
adjacent tubulin molecule and thus prevents a good initial contact between the colchi- 
cine and the colchicine binding site of the tubulin molecule. To test these possibilities 
we have chosen the B-ring analogues of colchicine viz., desacetamido colchicine and 
2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone which bind to tubulin at the same 
site at which colchicine binds (Ray et al.,  1981). The fluorometric results (figure 5) 
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clearly indicates that unlike colchicine, the binding of desacetamido colchicine and 2-
methoxy-5-(2’,3’,4’–trimethoxyphenyl) tropone was almost the same in the case of 
tubulin either in the polymerized or in the unpolymerized state. Similar results have 
also been obtained in the chasing experiment (figure 6). Thus, it appeared from this 
study that the A- and C-ring (of colchicine) binding domains on tubulin are exposed 
in the Zn(II)-induced polymers. Even the compound with A-, C-, and B-ring 
(desacetamido colchicine) could bind to tubulin in the assembled state whereas the 
presence of -NH CO.CH3 in the B-ring makes the compound inactive. Our 
experiments, however, do not distinguish whether this is purely a steric effects or due 
to a forbidden conformational change (as needed for colchicine binding) of tubulin in 
the assembled state. By what means the substituents on the B-ring of colchicine alter 
its binding properties with normal microtubules remain to be established. 
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